California is introducing a new electric vehicle rebate to replace the lost federal tax credit. The new state incentive will be limited to first-time electric vehicle buyers. The program includes caps ...

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--First Brands Group, LLC (“First Brands” or the “Company”), a leading global supplier of automotive parts, announced that it has commenced a wind down of ...

Sarah Tillman (center) holds up her bike with David Dick and Nora Banks at the Guttenberg marina during the final day of RAGBRAI in Guttenberg on July 26, 2025. Tillman said this is her sixth time ...

A new mom filming herself on her phone ended up capturing her toddler daughter doing something entirely unexpected instead. Sara, from Florida, had just finished work and was recording herself ...

The 2025 NFL postseason has narrowed its field to a fascinating mix of old-guard dynasties and modern powerhouses. As the Divisional Round begins this week, the pressure isn’t just about the current ...

With a White House drug pricing deal done and dusted and the threat of tariffs ameliorated, Sanofi is enjoying more clarity from the U.S. government now than the same time last year. But several ...

Daylight Saving Time in 2026 will begin on Sunday, March 8, and end on Sunday, November 1. Despite some states' legislative efforts, Daylight Saving Time is not set to end in the United States.

Federal military officials have ordered the demobilization of 100 Oregon National Guard troops who were called up to clamp down on immigration enforcement protests in Portland but have spent most of ...

Choi Woo Shik and Jang Hye Jin, who portrayed a mother and son in the award-winning film “Parasite,” are reuniting as a mother–son duo again after six years! On December 22, the upcoming film “Number ...

Shortest path algorithms sit at the heart of modern graph theory and many of the systems that move people, data, and goods around the world. After nearly seventy years of relying on the same classic ...

HORSHAM, Pa., Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), ...